...
首页> 外文期刊>Allergology international: official journal of the Japanese Society of Allergology >Nakajo-Nishimura syndrome: An autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy
【24h】

Nakajo-Nishimura syndrome: An autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy

机译:Nakajo-Nishimura综合征:一种自发炎性疾病,表现为膜炎样皮疹和进行性部分脂肪营养不良

获取原文
获取原文并翻译 | 示例
           

摘要

Nakajo-Nishimura syndrome (ORPHA2615; also registered as Nakajo syndrome in OMIM#256040) is a distinct inherited inflammatory and wasting disease, originally reported from Japan. This disease usually begins in early infancy with a pernio-like rash, especially in winter. The patients develop periodic high fever and nodular erythema-like eruptions, and gradually progress lipomuscular atrophy in the upper body, mainly the face and the upper extremities, to show the characteristic thin facial appearance and long clubbed fingers with joint contractures. So far about 30 cases have been reported from Kansai, especially Wakayama and Osaka, Tohoku and Kanto areas. At present, about 10 cases are confirmed to be alive only in the Kansai area, including one infant case in Wakayama. However, more cases are expected to be added in the near future. Although cause of the disease has long been undefined, a homozygous mutation of the PSMB8 gene, which encodes the β5i subunit of immunoproteasome, has been identified to be responsible in 2011. By analyses of the patientsderived cells and tissues, it has been suggested that accumulation of ubiquitinated and oxidated proteins due to immunoproteasome dysfunction causes hyperactivation of p38 mitogen-activated protein kinase and interleukin-6 overproduction. Since similar diseases with PSMB8 mutations have recently been reported from Europe and the United States, it is becoming clear that Nakajo-Nishimura syndrome and related disorders form proteasome disability syndromes, a new category of autoinflammatory diseases distributed globally.
机译:Nakajo-Nishimura综合征(ORPHA2615;也已在OMIM#256040中注册为Nakajo综合征)是一种独特的遗传性炎症和浪费性疾病,最初报道于日本。该病通常始于婴儿早期,伴有疱疹样皮疹,尤其是在冬天。患者会出现周期性的高烧和结节性红斑样爆发,并逐渐在上半身(主要是面部和上肢)进行脂肪性肌萎缩,表现出特征性的瘦脸和长关节指状长棍状手指。迄今为止,关西地区已报告了30例病例,特别是和歌山和大阪,东北和关东地区。目前,已确认仅在关西地区还活着约10例,其中和歌山有1例婴儿。但是,预计在不久的将来还会增加更多的案件。尽管该病的病因长期未明,但已确定编码免疫蛋白酶体β5i亚基的PSMB8基因的纯合突变是在2011年引起的。通过对患者衍生的细胞和组织进行分析,已表明其积累免疫蛋白酶体功能障碍引起的泛素化和氧化蛋白的缺失会导致p38丝裂原活化蛋白激酶的过度活化和白介素6的过度生产。由于最近已在欧洲和美国报道了具有PSMB8突变的类似疾病,因此越来越明显的是,Nakajo-Nishimura综合征和相关疾病形成了蛋白酶体残疾综合征,这是一种在全球范围内分布的新型自体炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号